相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management
Jooho Lee et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias
Christopher T. Johansen et al.
JOURNAL OF LIPID RESEARCH (2014)
Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids
Marius R. Robciuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Recent developments in the genetics of LDL deficiency
Amanda J. Hooper et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis
Ilenia Minicocci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis
Ilenia Minicocci et al.
JOURNAL OF LIPID RESEARCH (2013)
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia
Davide Noto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Low Rate of Production of Apolipoproteins B100 and AI in 2 Patients With Anderson Disease (Chylomicron Retention Disease)
Khadija Ouguerram et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Mutations in the ANGPTL3 Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization
Ilenia Minicocci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The PCSK9 decade
Gilles Lambert et al.
JOURNAL OF LIPID RESEARCH (2012)
Multiple functions of microsomal triglyceride transfer protein
M. Mahmood Hussain et al.
NUTRITION & METABOLISM (2012)
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
M. E. Visser et al.
DIABETOLOGIA (2011)
Thematic Review Series: Genetics of Human Lipid Diseases Genetic determinants of hepatic steatosis in man
Amanda J. Hooper et al.
JOURNAL OF LIPID RESEARCH (2011)
Nonsynonymous Mutations within APOB in Human Familial Hypobetalipoproteinemia EVIDENCE FOR FEEDBACK INHIBITION OF LIPOGENESIS AND POSTENDOPLASMIC RETICULUM DEGRADATION OF APOLIPOPROTEIN B
Shumei Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vitamin E and neurological function
David P. R. Muller
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia
Kiran Musunuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers
Noel Peretti et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human pasma
K. Nakajima et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia
Bertrand Cariou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The Angiopoietin-like Proteins ANGPTL3 and ANGPTL4 Inhibit Lipoprotein Lipase Activity through Distinct Mechanisms
Lu Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Chylomicron retention disease: A long term study of two cohorts
Noel Peretti et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Abetalipoproteinemia: two case reports and literature review
Rola Zamel et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Missense mutations in APOB within the βα1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia
John R. Burnett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population
Amanda J. Hooper et al.
ATHEROSCLEROSIS (2007)
Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia
Michael W. Clarke et al.
CLINICAL CHEMISTRY (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote
Zhenze Zhao et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia
RR Sankatsing et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Familial hypobetalipoproteinemia: genetics and metabolism
G Schonfeld et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
C Jonathan et al.
NATURE GENETICS (2005)
Lipid disorders and mutations in the APOB gene
AJ Whitfield et al.
CLINICAL CHEMISTRY (2004)
Fatty liver in familial hypobetalipoproteinemia:: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity
T Tanoli et al.
JOURNAL OF LIPID RESEARCH (2004)
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
B Jones et al.
NATURE GENETICS (2003)
A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia
JR Burnett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis
G Schonfeld et al.
JOURNAL OF LIPID RESEARCH (2003)
COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle
SA Siddiqi et al.
JOURNAL OF CELL SCIENCE (2003)
Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients
I Chowers et al.
EYE (2001)
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5)
P Tarugi et al.
JOURNAL OF HEPATOLOGY (2000)